BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 18281482)

  • 1. Efficient identification of a novel cancer/testis antigen for immunotherapy using three-step microarray analysis.
    Yokoe T; Tanaka F; Mimori K; Inoue H; Ohmachi T; Kusunoki M; Mori M
    Cancer Res; 2008 Feb; 68(4):1074-82. PubMed ID: 18281482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infrequent and low expression of cancer-testis antigens located on the X chromosome in colorectal cancer: implications for immunotherapy in South African populations.
    Dakshinamurthy AG; Ramesar R; Goldberg P; Blackburn JM
    Biotechnol J; 2008 Nov; 3(11):1417-23. PubMed ID: 18956367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a novel tumor-associated antigen, cadherin 3/P-cadherin, as a possible target for immunotherapy of pancreatic, gastric, and colorectal cancers.
    Imai K; Hirata S; Irie A; Senju S; Ikuta Y; Yokomine K; Harao M; Inoue M; Tsunoda T; Nakatsuru S; Nakagawa H; Nakamura Y; Baba H; Nishimura Y
    Clin Cancer Res; 2008 Oct; 14(20):6487-95. PubMed ID: 18927288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opa interacting protein 5 (OIP5) is a novel cancer-testis specific gene in gastric cancer.
    Nakamura Y; Tanaka F; Nagahara H; Ieta K; Haraguchi N; Mimori K; Sasaki A; Inoue H; Yanaga K; Mori M
    Ann Surg Oncol; 2007 Feb; 14(2):885-92. PubMed ID: 17151793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression profile of cancer-testis genes in 121 human colorectal cancer tissue and adjacent normal tissue.
    Li M; Yuan YH; Han Y; Liu YX; Yan L; Wang Y; Gu J
    Clin Cancer Res; 2005 Mar; 11(5):1809-14. PubMed ID: 15756003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of secernin 1 as a novel immunotherapy target for gastric cancer using the expression profiles of cDNA microarray.
    Suda T; Tsunoda T; Uchida N; Watanabe T; Hasegawa S; Satoh S; Ohgi S; Furukawa Y; Nakamura Y; Tahara H
    Cancer Sci; 2006 May; 97(5):411-9. PubMed ID: 16630140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a novel cancer-testis antigen CRT2 frequently expressed in various cancers using representational differential analysis.
    Hayashi E; Matsuzaki Y; Hasegawa G; Yaguchi T; Kurihara S; Fujita T; Kageshita T; Sano M; Kawakami Y
    Clin Cancer Res; 2007 Nov; 13(21):6267-74. PubMed ID: 17975137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of TROP2 expression in colorectal cancer.
    Ohmachi T; Tanaka F; Mimori K; Inoue H; Yanaga K; Mori M
    Clin Cancer Res; 2006 May; 12(10):3057-63. PubMed ID: 16707602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer/testis (CT) antigens: potential targets for immunotherapy.
    Caballero OL; Chen YT
    Cancer Sci; 2009 Nov; 100(11):2014-21. PubMed ID: 19719775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation of LEM domain-containing 1, a novel testis-specific gene expressed in colorectal cancers.
    Yuki D; Lin YM; Fujii Y; Nakamura Y; Furukawa Y
    Oncol Rep; 2004 Aug; 12(2):275-80. PubMed ID: 15254688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a novel, testis-specific equine serine/threonine kinase.
    Sabeur K; Ball BA; Corbin CJ; Conley A
    Mol Reprod Dev; 2008 May; 75(5):867-73. PubMed ID: 18246530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression profiling identifies BAX-delta as a novel tumor antigen in acute lymphoblastic leukemia.
    Maia S; Haining WN; Ansén S; Xia Z; Armstrong SA; Seth NP; Ghia P; den Boer ML; Pieters R; Sallan SE; Nadler LM; Cardoso AA
    Cancer Res; 2005 Nov; 65(21):10050-8. PubMed ID: 16267031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CABYR is a novel cancer-testis antigen in lung cancer.
    Luo C; Xiao X; Liu D; Chen S; Li M; Xu A; Liu J; Gao S; Wu S; He D
    Clin Cancer Res; 2007 Feb; 13(4):1288-97. PubMed ID: 17317841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sperm-associated antigen 9, a novel cancer testis antigen, is a potential target for immunotherapy in epithelial ovarian cancer.
    Garg M; Chaurasiya D; Rana R; Jagadish N; Kanojia D; Dudha N; Kamran N; Salhan S; Bhatnagar A; Suri S; Gupta A; Suri A
    Clin Cancer Res; 2007 Mar; 13(5):1421-8. PubMed ID: 17332284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and characterization of a novel cancer/testis antigen gene CAGE.
    Cho B; Lim Y; Lee DY; Park SY; Lee H; Kim WH; Yang H; Bang YJ; Jeoung DI
    Biochem Biophys Res Commun; 2002 Apr; 292(3):715-26. PubMed ID: 11922625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of the L-plastin gene in human colorectal cancer progression and metastasis.
    Otsuka M; Kato M; Yoshikawa T; Chen H; Brown EJ; Masuho Y; Omata M; Seki N
    Biochem Biophys Res Commun; 2001 Dec; 289(4):876-81. PubMed ID: 11735128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a new cancer/germline gene, KK-LC-1, encoding an antigen recognized by autologous CTL induced on human lung adenocarcinoma.
    Fukuyama T; Hanagiri T; Takenoyama M; Ichiki Y; Mizukami M; So T; Sugaya M; So T; Sugio K; Yasumoto K
    Cancer Res; 2006 May; 66(9):4922-8. PubMed ID: 16651449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a novel prostate cancer-associated tumor antigen.
    Miles AK; Rogers A; Li G; Seth R; Powe D; McArdle SE; McCulloch TA; Bishop MC; Rees RC
    Prostate; 2007 Feb; 67(3):274-87. PubMed ID: 17192878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of cancer/testis-antigen genes by massively parallel signature sequencing.
    Chen YT; Scanlan MJ; Venditti CA; Chua R; Theiler G; Stevenson BJ; Iseli C; Gure AO; Vasicek T; Strausberg RL; Jongeneel CV; Old LJ; Simpson AJ
    Proc Natl Acad Sci U S A; 2005 May; 102(22):7940-5. PubMed ID: 15905330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sperm-associated antigens as targets for cancer immunotherapy: expression pattern and humoral immune response in cancer patients.
    Siliņa K; Zayakin P; Kalniņa Z; Ivanova L; Meistere I; Endzeliņš E; Abols A; Stengrēvics A; Leja M; Ducena K; Kozirovskis V; Linē A
    J Immunother; 2011 Jan; 34(1):28-44. PubMed ID: 21150711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.